LUNA Beauty Tirzepatide 15mg

Tirzepatide is a dual incretin mimetic, consisting of 39 amino acids, meaning it acts on both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action results in:

• Enhanced insulin sensitivity
• Appetite suppression through GLP-1 pathways seen in Semaglutide
• Improved fat metabolism and energy utilisation via GIP
• Better blood glucose control and lower postprandial insulin spikes GIP also seems to play a role in lipid handling and adipocyte (fat cell) signalling, which may explain why Tirzepatide has shown even greater fat loss potential compared to semaglutide in head-to-head trials. Therapeutic Applications
• Advanced fat loss in resistant individuals
• Enhanced glycaemic control in pre-diabetic or diabetic users
• Appetite control with improved energy partitioning
• Metabolic reset for individuals with chronically elevated insulin or poor nutrient signalling
• Potential cognitive benefits via insulin signalling modulation in the brain

**Side Effects **

• Nausea
• Mild bloating or GI discomfort
• Fatigue or fullness during eating
• Suppressed appetite beyond what’s functionally useful
• Hypoglycaemia episodes
• Headaches
• Low mood from chronic under-fuelling These side effects can be minimised by sticking to lower doses that are better tolerated, sticking to a hierarchy of nutrients such as hydration, electrolytes, nutrient-dense foods, high protein, dietary fibre, and adequate food intake

Use Cases

• Advanced fat loss: Outperforms GLP-1s alone by combining dual incretin signalling, helping break through fat loss plateaus and improve overall body composition
• Metabolic reset: Ideal for individuals with chronically high insulin, poor glycaemic control, or adaptive resistance to fat loss despite structured nutrition and training
• Insulin sensitivity improvement: GIP pathway enhances insulin response and nutrient partitioning, supporting lean mass preservation and better post-meal glucose control
• Appetite regulation with energy balance: Helps control hunger without flatlining energy or mood when dosed appropriately within a performance-based protocol
• Adipose signalling modulation: Improves hormonal markers tied to fat metabolism (like adiponectin and leptin), supporting a more favourable metabolic profile even after cessation
• Cognitive crossover potential: May positively impact brain insulin sensitivity and reward regulation, offering benefits for individuals with poor impulse control or emotional eating